| scholarly article | Q13442814 |
| P2093 | author name string | Michelle T Ma | |
| Philip J Blower | |||
| Thomas R Eykyn | |||
| Brett M Paterson | |||
| Andrew Cakebread | |||
| Calum A Foley | |||
| Jennifer D Young | |||
| Cinzia Imberti | |||
| Catherine R Munteanu | |||
| Caroline E Knapp | |||
| Maria Iris Tsionou | |||
| P2860 | cites work | A short history of SHELX | Q25938995 |
| 68Ga-Based radiopharmaceuticals: production and application relationship | Q26801794 | ||
| Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability | Q27339846 | ||
| High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours | Q28260008 | ||
| Approaching 'Kit-Type' Labelling with (68)Ga: The DATA Chelators | Q30938260 | ||
| Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity | Q31062644 | ||
| Iron binding dendrimers: a novel approach for the treatment of haemochromatosis | Q33248894 | ||
| Dissociation kinetics of Mn2+ complexes of NOTA and DOTA. | Q33805938 | ||
| Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium. | Q34119384 | ||
| Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B. | Q35170338 | ||
| Crystal structure refinement with SHELXL. | Q35539543 | ||
| Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate | Q36143456 | ||
| Affibody-mediated PET imaging of HER3 expression in malignant tumours. | Q36174716 | ||
| New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.). | Q36595679 | ||
| Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer | Q37350456 | ||
| Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands | Q37594420 | ||
| Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68. | Q37631557 | ||
| Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of αvβ3 Integrin Expression with Gallium-68. | Q37648915 | ||
| In vivo imaging with antibodies and engineered fragments. | Q38454458 | ||
| 68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling | Q38707752 | ||
| [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation | Q38933775 | ||
| (68)Ga small peptide imaging: comparison of NOTA and PCTA. | Q39266092 | ||
| RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga | Q39387478 | ||
| 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging | Q39389586 | ||
| Gallium-68 complex of a macrobicyclic cage amine chelator tethered to two integrin-targeting peptides for diagnostic tumor imaging | Q39482236 | ||
| Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis | Q39505469 | ||
| Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET. | Q39605627 | ||
| ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature | Q39706929 | ||
| Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates | Q40404320 | ||
| Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors | Q40557870 | ||
| Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer | Q41905456 | ||
| A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography. | Q42167262 | ||
| Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies. | Q42837828 | ||
| Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration | Q42854505 | ||
| The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy | Q43059527 | ||
| Structural and in vivo studies of metal chelates of Ga(III) relevant to biomedical imaging | Q43503623 | ||
| NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors | Q43992775 | ||
| Influence of metal ions on the ⁶⁸Ga-labeling of DOTATATE. | Q45906319 | ||
| Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature | Q46801081 | ||
| Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga | Q47992491 | ||
| 68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer. | Q50556005 | ||
| Ethanol-Based Post-processing of Generator-Derived ⁶⁸Ga Toward Kit-Type Preparation of ⁶⁸Ga-Radiopharmaceuticals. | Q51740399 | ||
| 68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors. | Q53277538 | ||
| OLEX2: a complete structure solution, refinement and analysis program | Q56812809 | ||
| DATATOC: a novel conjugate for kit-type Ga labelling of TOC at ambient temperature | Q59470095 | ||
| Crystallographic and solution NMR structural analyses of four hexacoordinated gallium(iii) complexes based on ligands derived from 6-amino-perhydro-1,4-diazepine | Q60171670 | ||
| Structure and stability of hexadentate complexes of ligands based on AAZTA for efficient PET labelling with gallium-68 | Q60171678 | ||
| Kinetics of Ga(NOTA) Formation from Weak Ga-Citrate Complexes | Q60319119 | ||
| H2CHXdedpa and H4CHXoctapa—Chiral Acyclic Chelating Ligands for 67/68Ga and 111In Radiopharmaceuticals | Q60452051 | ||
| Processing of generator-produced 68Ga for medical application. | Q64947317 | ||
| A bifunctional HBED-derivative for labeling of antibodies with 67Ga, 111In and 59Fe. Comparative biodistribution with 111In-DPTA and 131I-labeled antibodies in mice bearing antibody internalizing and non-internalizing tumors | Q67577927 | ||
| The chemistry of gallium and indium as related to radiopharmaceutical production | Q70564303 | ||
| Metal ion speciation in blood plasma: gallium-67-citrate and MRI contrast agents | Q71152383 | ||
| Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies | Q72742120 | ||
| Calorimetric, spectroscopic, and model studies provide insight into the transport of Ti(IV) by human serum transferrin | Q79814043 | ||
| Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals | Q82995132 | ||
| Macrobicyclic cage amine ligands for copper radiopharmaceuticals: a single bivalent cage amine containing two Lys3-bombesin targeting peptides | Q84344831 | ||
| Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1H)-pyridones - Attempted optimization of the orally active iron chelator, deferiprone | Q89062664 | ||
| P433 | issue | 78 | |
| P304 | page(s) | 49586-49599 | |
| P577 | publication date | 2017-10-25 | |
| P1433 | published in | RSC Advances | Q15716379 |
| P1476 | title | Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling | |
| P478 | volume | 7 |
| Q91675187 | Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications |
| Q64269161 | Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies |
| Q94156373 | INVITED ORAL PRESENTATIONS |
| Q94230870 | INVITED ORAL PRESENTATIONS |
| Q64897716 | Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC. |
| Q89879563 | Manipulating the In Vivo Behaviour of 68Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood Clearance |
| Q58723385 | Preclinical Evaluation of [Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors |
| Q98394652 | Radiosynthesis and preclinical evaluation of [68Ga]Ga-NOTA-folate for PET imaging of folate receptor β-positive macrophages |
| Q90455222 | Theranostic Gallium Siderophore Ciprofloxacin Conjugate with Broad Spectrum Antibiotic Potency |
| Q64101828 | Tuning the properties of tris(hydroxypyridinone) ligands: efficient Ga chelators for PET imaging |
Search more.